Trial · NCT01376362
Results by group17
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 17 of 17
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Excess Central Macular Thickening in the Study Eye, as Measured by Optical Coherence Tomography (OCT), at Week One Compared to Baseline | Interferon Gamma-1b | -38.60 | Standard Deviation 130.26 | µm | |
| Change in Excess Central Macular Thickening in the Fellow Eye, as Measured by Optical Coherence Tomography (OCT), at Week One Compared to Baseline | Interferon Gamma-1b | 12.00 | Standard Deviation 29.12 | µm | |
| Change in Excess Central Macular Thickening in the Study Eye, as Measured by Optical Coherence Tomography (OCT), at Week Two Compared to Baseline | Interferon Gamma-1b | -47.40 | Standard Deviation 85.96 | µm | |
| Change in Excess Central Macular Thickening in the Fellow Eye, as Measured by Optical Coherence Tomography (OCT), at Week Two Compared to Baseline | Interferon Gamma-1b | 30.20 | Standard Deviation 64.43 | µm | |
| Change in Macular Volume in the Study Eye, as Measured by Optical Coherence Tomography (OCT), at Week One Compared to Baseline | Interferon Gamma-1b | -0.02 | Standard Deviation 0.36 | mm^3 | |
| Change in Macular Volume in the Fellow Eye, as Measured by Optical Coherence Tomography (OCT), at Week One Compared to Baseline | Interferon Gamma-1b | 0.14 | Standard Deviation 0.21 | mm^3 | |
| Change in Macular Volume in the Study Eye, as Measured by Optical Coherence Tomography (OCT), at Week Two Compared to Baseline | Interferon Gamma-1b | 0.00 | Standard Deviation 0.32 | mm^3 | |
| Change in Macular Volume in the Fellow Eye, as Measured by Optical Coherence Tomography (OCT), at Week Two Compared to Baseline | Interferon Gamma-1b | 0.06 | Standard Deviation 0.34 | mm^3 | |
| Change in ETDRS Best-corrected Visual Acuity (BCVA) in the Study Eye at Week One Compared to Baseline | Interferon Gamma-1b | 0.20 | Standard Deviation 5.63 | ETDRS Letters | |
| Change in ETDRS Best-corrected Visual Acuity (BCVA) in the Fellow Eye at Week One Compared to Baseline | Interferon Gamma-1b | 1.60 | Standard Deviation 4.72 | ETDRS Letters | |
| Change in ETDRS Best-corrected Visual Acuity (BCVA) in the Study Eye at Week Two Compared to Baseline | Interferon Gamma-1b | 4.00 | Standard Deviation 9.03 | ETDRS Letters | |
| Change in ETDRS Best-corrected Visual Acuity (BCVA) in the Fellow Eye at Week Two Compared to Baseline | Interferon Gamma-1b | 3.20 | Standard Deviation 6.87 | ETDRS Letters | |
| Change in Intraocular Pressure (IOP) in the Study Eye at Week One Compared to Baseline | Interferon Gamma-1b | 0.40 | Standard Deviation 2.07 | mm Hg | |
| Change in Intraocular Pressure (IOP) in the Fellow Eye at Week One Compared to Baseline | Interferon Gamma-1b | -1.60 | Standard Deviation 7.02 | mm Hg | |
| Change in Intraocular Pressure (IOP) in the Study Eye at Week Two Compared to Baseline | Interferon Gamma-1b | 0.40 | Standard Deviation 1.34 | mm Hg | |
| Change in Intraocular Pressure (IOP) in the Fellow Eye at Week Two Compared to Baseline | Interferon Gamma-1b | -2.20 | Standard Deviation 7.40 | mm Hg | |
| Proportion of Participants With a Visual Loss of 15 or More Early Treatment Diabetic Retinopathy Study (ETDRS) Letters in the Study Eye | Interferon Gamma-1b | 0 | Percentage of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01376362/results